If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Form 8.3 - Charles Stanley Group Plc

2 Aug 2021 15:20

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

Aberforth Partners LLP - Form 8.3 - Charles Stanley Group Plc

PR Newswire

London, August 2

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON

WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Aberforth Partners LLP, on behalf of discretionary clients.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Charles Stanley Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 30/07/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/A NO If YES, specify which:

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 4,563,777 8.75% 0 0.0
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 4,563,777 8.75% 0 0.0

Aberforth Partners LLP does not have discretion regarding voting decisions in respect of 1,399,602 shares included in the total disclosed above. This total includes 1,399,602 shares held by The Wellcome Trust, who retain voting control over their shareholding. No other client, who falls into this category, holds more than 1% of the relevant security.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:N/A
Details, including nature of the rights concerned and relevant percentages:N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
Ordinary Shares Sale 3,500,000  510.3p

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 02 August 2021
Contact name:Michael Campbell, for Aberforth Partners LLP
Telephone number:0131 220 0733

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
29th Jul 201012:52 pmRNSAGM Results
29th Jul 20107:00 amRNSInterim Management Statement
26th Jul 201011:55 amRNSDirector/PDMR Shareholding
16th Jul 20103:31 pmRNSHolding(s) in Company
1st Jul 201010:29 amRNSAnnual Information Update
29th Jun 201010:00 amRNSPosting of Annual Report and Accounts
28th Jun 20104:35 pmRNSPrice Monitoring Extension
23rd Jun 201012:09 pmRNSScrip Dividend Scheme Share Price
18th Jun 20102:08 pmRNSDirector/PDMR Shareholding
14th Jun 201010:33 amRNSDirector/PDMR Shareholding
11th Jun 20101:44 pmRNSDirector/PDMR Shareholding
10th Jun 20104:13 pmRNSHolding(s) in Company
8th Jun 20107:00 amRNSFinal Results
12th Apr 201011:03 amRNSHolding(s) in Company
6th Apr 20102:11 pmRNSHolding(s) in Company
1st Apr 201012:44 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 201010:09 amRNSDirector/PDMR Shareholding
30th Mar 20109:31 amRNSTotal Voting Rights
24th Mar 20103:18 pmRNSDirector/PDMR Shareholding
5th Mar 20102:34 pmRNSDirector/PDMR Shareholding
17th Feb 20102:17 pmRNSDirector/PDMR Shareholding
10th Feb 20102:18 pmRNSScrip Dividend Scheme Share Price
5th Feb 20102:38 pmRNSDirector/PDMR Shareholding
3rd Feb 201012:32 pmRNSDirector/PDMR Shareholding
1st Feb 20102:45 pmRNSDirector/PDMR Shareholding
27th Jan 20107:00 amRNSInterim Management Statement
31st Dec 200910:00 amRNSDirector/PDMR Shareholding
30th Dec 20092:43 pmRNSTotal Voting Rights
22nd Dec 20093:59 pmRNSDirector/PDMR Shareholding
22nd Dec 20093:37 pmRNSDirector/PDMR Shareholding
26th Nov 20093:01 pmRNSDirector/PDMR Shareholding
19th Nov 20093:16 pmRNSScrip price
5th Nov 20097:00 amRNSHalf Yearly Report
15th Oct 200910:23 amRNSHolding(s) in Company
30th Sep 20094:29 pmRNSDirector/PDMR Shareholding
23rd Sep 20099:55 amRNSHolding(s) in Company
17th Sep 20093:21 pmRNSHolding(s) in Company
11th Sep 20094:33 pmRNSHolding(s) in Company
2nd Sep 20094:00 pmRNSHolding(s) in Company
28th Aug 200910:07 amRNSTotal Voting Rights
4th Aug 20095:19 pmRNSHolding(s) in Company
3rd Aug 20093:58 pmRNSFinal Dividend and Changes to PDMR interests-Amend
28th Jul 20096:02 pmRNSFinal Dividend and Changes to PDMR Interests
28th Jul 20095:58 pmRNSResult of AGM
28th Jul 20097:00 amRNSInterim Management Statement
24th Jul 20094:03 pmRNSHolding(s) in Company
3rd Jul 20098:41 amRNSDocuments available for inspection
30th Jun 20094:04 pmRNSAnnual Information Update
30th Jun 20094:02 pmRNSPosting of Annual Report and Accounts
12th Jun 20099:09 amRNSAppointment of Joint Adviser and Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.